Oncology
5 drugs are in development for NSCLC.
- Companies
- 4
- Clinical trials
- 44
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the NSCLC pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 3(3)
Phase 1(1)
| Drug | Company |
|---|---|
| CFT1946 | C4 Therapeutics, Inc. (CCCC) |
Phase 1/Phase 2(1)
| Drug | Company |
|---|---|
| lp-184 | Lantern Pharma Inc. (LTRN) |
About this indication
NSCLC context
Oncology·MeSH: Neoplasm Metastasis (D009362)
Narrower concept of MeSH descriptor Neoplasm Metastasis
Compare drugs
Frequently asked questions
How many drugs are in development for NSCLC?
BioSniper tracks 5 drugs in development for NSCLC across 4 companies.
How many clinical trials target NSCLC?
There are 44 clinical trials targeting NSCLC tracked by BioSniper.